drugset / Trial / NCT04874142

Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A

NCT04874142 ↗

Phase 1 Completed 48 enrolled Yooyoung Pharmaceutical Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the safety and pharmacokinetics drug-drug interaction of YYC506-T and YYC506-A

Timeline

Start
2019-11-20
Primary completion
2020-03-23
Completion
2020-03-23

Drugs

EvaluationDrugModalityDoseRoute
Subject YYC506-A Unknown — Oral
Subject YYC506-T Unknown — Oral

Indications